The Cambridge Cellular Therapy Programme at CUH has maintained accreditation to the stringent international standards for cellular therapy set by The Joint Accreditation Committee of ISCT and EMBT (JACIE) since 2007.
These are the European Group for Blood and Marrow Transplantation (EBMT) and the International Society for Cellular Therapy (ISCT).
This set of standards is regularly reviewed and is continually evolving, ensuring that our services progress and improve over time.
This accreditation includes the following:
- Autologous and Allogenic Transplantation in Adult Patients
- Autologous and Allogenic Transplantation in Paediatric Patients
- Collection of HPC, Marrow
- Collection of HPC, Apheresis
- Cell Processing - minimally manipulated
Accreditation details
- Accreditation Body: Joint Accreditation Committee ISCT-EBMT (JACIE)
- Organisation: Cambridge and Ipswich BMT and Cellular Therapy Programme (Addenbrooke’s Hospital, Cambridge, United Kingdom)
- Accreditation Standard: FACT-JACIE International Standards for Cellular Therapy, 8th Edition
- Scopes Covered:
- Autologous & Allogeneic Transplantation in Adult Patients
- Autologous & Allogeneic Transplantation in Paediatric Patients
- Immune Effector Cells Administration
- Collection of HPC, Marrow
- Collection of HPC, Apheresis
- Cell Processing – minimally manipulated
- Certificate ID: 1,284
- Date of Issue: 16 January 2025
- Date of Expiry: 15 January 2029
- Signed by:
- Dr Bruna Magalhaes Gotardo, JACIE Medical Officer
- Lynn Manson, Chair, JACIE Accreditation Committee
